Correction to: Eculizumab treatment and discontinuation in pediatric patients with atypical hemolytic uremic syndrome: a multicentric retrospective study
J Nephrol
.
2022 May;35(4):1309.
doi: 10.1007/s40620-022-01265-5.
Authors
Esra Baskin
1
,
Kibriya Fidan
2
,
Bora Gulhan
3
,
Kaan Gulleroglu
1
,
Nur Canpolat
4
,
Alev Yilmaz
5
,
Gonül Parmakiz
6
,
Zeynep Birsin Özçakar
7
,
Fatih Ozaltin
3
,
Oguz Soylemezoglu
8
Affiliations
1
Department of Pediatric Nephrology, Başkent University, Ankara, Turkey.
2
Department of Pediatric Nephrology, School of Medicine, Gazi University, Ankara, Turkey.
[email protected]
.
3
Department of Pediatric Nephrology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
4
Department of Pediatric Nephrology, Istanbul University-Cerrahpasa, İstanbul, Turkey.
5
Department of Pediatric Nephrology, Istanbul University Istanbul School of Medicine, İstanbul, Turkey.
6
Department of Pediatric Nephrology, Başkent University Adana Dr. Turgut Noyan Training and Research Center, Adana, Turkey.
7
Department of Pediatric Nephrology, Ankara University Medical School, Ankara, Turkey.
8
Department of Pediatric Nephrology, School of Medicine, Gazi University, Ankara, Turkey.
PMID:
35129816
DOI:
10.1007/s40620-022-01265-5
No abstract available
Publication types
Published Erratum